Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Northern Areas of Pakistan in Winter Northern Areas in Summer LEUKEMIAS BY DR WAQAR ALI ASST. PROFESSOR NORMAL HEMATOPOEISIS IN THE BONE MARROW DEFINITION Leukemia is a malignant neoplasm ( cancer) of the “precursors” of WBCs in the bone marrow. There is excess formation of these cells and they are functionally abnormal If it develops from the myeloid stem cells, it is called Myeloid leukemia, and if it develops from lymphoid stem cells, it is called Lymphoid leukemia. CLASSIFICATION OF LEUKEMIAS ACUTE Develops quickly in a short time CHRONIC Develops slowly over longer time CLASSIFICATION (contd) ACUTE LEUKEMIA myeloid ( AML) lymphoblastic ( A.L.L.) If the leukemia arises from myeloblast, it is called acute myeloid leukemia. If it arises from the lymphoblast, it is called acute lymphoblastic leukemia. ACUTE MYELOID LEUKEMIA It is the most common acute leukemia of adults. Pathogenesis: Genetic damage in the myeloblast causes excess proliferation too many abnormal myeloblasts are produced which don’t function normally. These leukemic cells accumulate in the marrow and also enter the blood & other organs • Age Group: Mostly seen in old people (middle to old age). • Frequency: Rare. 100/100,000 ppl every yr. • Classification of AML: * W.H.O. classification * F.A.B. classification(French-American-British) Classification is based on the appearance of cells, immunophenotyping and genetic abnormality in the cells RISK FACTORS 1) Myelodysplastic Syndrome (MDS): A patient wth. MDS has increased risk of getting AML 2) Chemotherapy for other cancers can also increase the risk 3) Radiation exposure : eg cancer radiotherapy, atomic bombings in Japan ( radiologists don’t have a high risk due to modern day safety practices in X-Ray rooms) Risks ( contd) 4) Genetics: * more common in a twin if the first is affected. * More chance in genetic diseases like Down’s syndrome ( 10-18 times more) . S/S S/S occur mainly due to replacement of normal cells of the marrow by the leukemic cells. So, 1) Low RBCs: Features of anemia ( fatigue etc) 2) Low WBC : Infections 3) Low platelets: Bruising/ bleeding Also, leukemic cells can infiltrate other organs & cause hepatomegaly, splenomegaly , lymph node enlargement, gum hypertrophy,CNS involvement Sometimes, patients are asymptomatic & discovered only on routine blood tests. DIAGNOSTIC TESTS 1) CBC * Mostly, high WBC ( rarely norm. or low) * Anemia * Low platelets 2) Peripheral Smear: * Shows characteristic “blast cells” with Auer rods ( intracellular needle shaped body) Blats cell w/ Auer rods Blast cell w/ Auer rods Tests ( contd) 3) Bone Marrow: Shows excess immature myeloblasts which are the leukemic cells. Other cell lines are decreased ( RBC, mature WBC, platelets) because the leukemic cells have replaced them. TREATMENT In many cases, AML is curable but the chance of cure depends on many factors specially chromosomal pattern in the cancer cells. Treatments used are: 1) Chemotherapy : Cytarabine, Daunorubicin 2) Stem cell transplant ( if chemo. fails or there is relapse of the cancer) 3) Treatment of Anemia & thrombocytopenia 4) Treatment of infections CAUTION ! Before starting chemo., first always treat the anemia, thrombocytopenia & any infections DURATION OF TREATMENT Treatment is given in 2 phases: 1) INDUCTION PHASE: * You give the 2 chemo drugs for a wk. This kills most cancer cells & they become undetectable. This is called “remission” of the cancer (by the induction chemo.) Remission does not mean cure ! Contd. 2) CONSOLIDATION PHASE: * Even after induction chemo., some cancer cells are left behind. * So, chemo. is given for a few more cycles to completely destroy the cells ( cure) PROGNOSIS • Overall prognosis is good and it is a curable cancer in many cases • Prognosis is poor if: * if it is secondary to MDS or radiation exposure or secondary to chemotherapy for another cancer. * if the leukemic cells have certain chromosomal abnormalities Plz wait for next topic